
    
      Primary:

      To evaluate the long-term safety and tolerability of seladelpar

      Secondary:

        -  To evaluate the long-term efficacy of seladelpar

        -  To evaluate the effect of seladelpar on patient-reported outcomes (pruritus)
    
  